➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

AstraZeneca
McKinsey
Colorcon
Express Scripts
Boehringer Ingelheim
Baxter

Last Updated: June 18, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Omecamtiv Mecarbil


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Omecamtiv Mecarbil?

Omecamtiv Mecarbil is an investigational drug.

There have been 10 clinical trials for Omecamtiv Mecarbil. The most recent clinical trial was a Phase 2 trial, which was initiated on December 7th 2018.

The most common disease conditions in clinical trials are Heart Failure, Ventricular Dysfunction, Left, and [disabled in preview]. The leading clinical trial sponsors are Amgen, Cytokinetics, and Servier.

There are forty-one US patents protecting this investigational drug and three hundred and sixty-seven international patents.

Recent Clinical Trials for Omecamtiv Mecarbil
TitleSponsorPhase
Omecamtiv Mecarbil Post-trial Access StudyAmgenPhase 3
Study to Assess the Effect of Omecamtiv Mecarbil (OM) on QT/QTc Intervals in Healthy SubjectsAmgenPhase 1
Study to Assess the Effect of Omecamtiv Mecarbil on Exercise Capacity in Subjects With Heart FailureCytokineticsPhase 3

See all Omecamtiv Mecarbil clinical trials

Clinical Trial Summary for Omecamtiv Mecarbil

Top disease conditions for Omecamtiv Mecarbil
Top clinical trial sponsors for Omecamtiv Mecarbil

See all Omecamtiv Mecarbil clinical trials

US Patents for Omecamtiv Mecarbil

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Omecamtiv Mecarbil   Try Before You Buy Compounds, compositions and methods Cytokinetics, Incorporated (South San Francisco, CA)   Try Before You Buy
Omecamtiv Mecarbil   Try Before You Buy sGC stimulators Ironwood Pharmaceuticals, Inc. (Cambridge, MA)   Try Before You Buy
Omecamtiv Mecarbil   Try Before You Buy Controlled release dosage form TRIASTEK, INC. (Nanjing, CN)   Try Before You Buy
Omecamtiv Mecarbil   Try Before You Buy sGC stimulators Ironwood Pharmaceuticals, Inc. (Cambridge, MA)   Try Before You Buy
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Omecamtiv Mecarbil

Drugname Country Document Number Estimated Expiration Related US Patent
Omecamtiv Mecarbil Argentina AR053405 2024-06-17   Try Before You Buy
Omecamtiv Mecarbil Australia AU2005264988 2024-06-17   Try Before You Buy
Omecamtiv Mecarbil Brazil BRPI0512193 2024-06-17   Try Before You Buy
Omecamtiv Mecarbil Canada CA2570999 2024-06-17   Try Before You Buy
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Baxter
Colorcon
Express Scripts
Merck
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.